Literature DB >> 9353135

Mobilization of Ca2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes.

R J Spencer1, W Jin, S A Thayer, S Chakrabarti, P Y Law, H H Loh.   

Abstract

In neuronal cell lines, activation of opioid receptors has been shown to mobilize intracellular Ca2+ stores. In this report, we describe the excitatory actions of opioid agonists on murine neuroblastoma neuro2a cells stably expressing either delta, mu, or kappa opioid receptors. Fura-2-based digital imaging was used to record opioid-induced increases in intracellular Ca2+ concentration ([Ca2+]i). Repeated challenges of delta, mu, or kappa opioid receptor expressing cells with 100 nM [D-Ala2,D-Leu5]-enkephalin (DADLE), [D-Ala2,N-Me-Phe4,Gly-ol]-enkephalin (DAMGO), or trans-(+/-)-3,4-dichloro N-methyl-N-(2-[1-pyrollidinyl] cyclohexyl) benzene acetamide (U-50488H), respectively, elicited reproducible Ca2+ responses. Non-transfected neuro2a cells did not respond to opioid agonists. Removal of extracellular Ca2+ from the bath prior to and during agonist challenge did not affect significantly the agonist-evoked increase in [Ca2+]i, indicating that the response resulted from the release of Ca2+ from intracellular stores. Naloxone reversibly inhibited responses in all three cell lines, confirming that they were mediated by opioid receptors. Expression of cloned opioid receptors in neuro2a cells, coupled with digital [Ca2+]i imaging, provides a model system for the study of opioid receptors and opioid-activated signaling processes. The fact that all three receptors coupled to the same intracellular signaling mechanism suggests that the primary functional difference between opioid responses in vivo results from their selective localization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353135     DOI: 10.1016/s0006-2952(97)00243-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

Review 1.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

2.  Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.

Authors:  Tara A Macey; Erin N Bobeck; Deborah M Hegarty; Sue A Aicher; Susan L Ingram; Michael M Morgan
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

Review 3.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

4.  Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Authors:  Santhanalakshmi Sundaramurthy; Balasubramaniam Annamalai; Devadoss J Samuvel; Toni S Shippenberg; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Neuropharmacology       Date:  2016-10-12       Impact factor: 5.250

Review 5.  Kinase cascades and ligand-directed signaling at the kappa opioid receptor.

Authors:  Michael R Bruchas; Charles Chavkin
Journal:  Psychopharmacology (Berl)       Date:  2010-04-17       Impact factor: 4.530

6.  Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids.

Authors:  W Xie; G M Samoriski; J P McLaughlin; V A Romoser; A Smrcka; P M Hinkle; J M Bidlack; R A Gross; H Jiang; D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells.

Authors:  C Harrison; S McNulty; D Smart; D J Rowbotham; D K Grandy; L A Devi; D G Lambert
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation.

Authors:  S W Park; Y He; S G Ha; H H Loh; L-N Wei
Journal:  Neuroscience       Date:  2008-01-16       Impact factor: 3.590

9.  Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.

Authors:  Yan Chen; Cheng Yang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

Review 10.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.